(Q74643437)
Statements
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group (English)
T F Reiss
P Chervinsky
R J Dockhorn
S Shingo
B Seidenberg